Evidence map›Paper›PMID 38856303›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors.

Sofie Ekroos, Jan Karregat, Elena Toffol, Johanna Castrén, Mikko Arvas, Katja van den Hurk

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sofie EkroosFaculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-2135-2545
Jan KarregatDonor Studies, Department of Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.ORCID 0000-0003-0838-4929
Elena ToffolFaculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-6757-7355
Johanna CastrénFinnish Red Cross, Blood Service (FRCBS), Research and Development, Helsinki, Finland.
Mikko ArvasFinnish Red Cross, Blood Service (FRCBS), Research and Development, Helsinki, Finland.ORCID 0000-0002-6902-8488
Katja van den HurkDonor Studies, Department of Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.ORCID 0000-0003-3241-6003

Funding

Finska LäkaresällskapetHelsingin Yliopisto Tutkijalääkäriohjelma K26Punainen Risti VeripalveluStichting Sanquin Bloedvoorziening PPOC-14-028Stichting Sanquin Bloedvoorziening PPOC-19-02
6 · The paper itself

Abstract

introductionTo prevent blood donors from developing iron deficiency (ferritin <15 μg/L) and subsequent anemia (hemoglobin <120 g/L), blood services rely on information about known risk factors, including the donor's sex and age. For example, while Finnish women are able to donate whole blood with a minimum donation interval of 91 days, women in the 18 to 25-year-old age group are recommended to donate no more than once per year. Menstrual blood loss is not accounted for in blood donation interval recommendations, despite being a known risk factor of iron deficiency. We aim to investigate to what extent menstrual bleeding is associated with ferritin and hemoglobin levels in female blood donors, and quantify the association of other menstruation-related variables not currently accounted for by blood services (i.e., use of hormonal contraception, heavy menstrual bleeding) with iron deficiency or anemia. MATERIAL AND

methodsThe study population consisted of 473 premenopausal and 491 postmenopausal Dutch whole blood donors. Exclusion criteria were current pregnancy, BMI ≥50, ferritin ≥200, pictorial blood assessment chart (PBAC) ≥400, and age <18 or ≥70 years. Menstrual blood loss was quantified using a PBAC, a semiquantitative method to evaluate the number of used menstrual products and the degree of staining. We identified predictors of log(ferritin)/hemoglobin and iron deficiency/anemia using Bayesian linear and logistic regression models and quantified the average percentage of variance in log(ferritin) and hemoglobin explained by the covariates.

resultsMenstrual blood loss accounted for most of the explained variance in hemoglobin (8%) and second only to the number of days since last donation for ferritin (8%). Heavy menstrual bleeding (PBAC ≥150, OR = 3.56 [1.45-8.85], prevalence 13%) was associated with anemia, and use of levonorgestrel-releasing intrauterine device was negatively associated with iron deficiency (OR = 0.06 [0.01-0.44]). After statistical control for menstrual blood loss, age was not associated with iron status.

conclusionsMenstrual blood loss and blood donation were the most important determinants of iron status in premenopausal women. Thus, results suggest that accounting for menstrual blood loss in donation interval guidelines may benefit blood donors.

Indexed as

Anemia, Iron-DeficiencyBlood DonorsFerritinsHemoglobinsPremenopauseAdultFemaleHumansMenorrhagiaMenstruationMiddle AgedRisk FactorsYoung AdultFerritinsHemoglobinsanemiablood donor healthferritinheavy menstrual bleedinghemoglobiniron deficiencymenstruationpictorial blood assessment chart

Identifiers

PMID38856303
PMCPMC11266725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.